
LINK . SPRINGER . COM {
}
Title:
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe β/β mice | Diabetologia
Description:
Aims/hypothesis Inhibitors of dipeptidyl peptidase-IV (DPP-IV), such as sitagliptin, increase glucagon-like peptide-1 (GLP-1) concentrations and are current treatment options for patients with type 2 diabetes mellitus. As patients with diabetes exhibit a high risk of developing severe atherosclerosis, we investigated the effect of sitagliptin on atherogenesis in Apoe β/β mice. Methods Apoe β/β mice were fed a high-fat diet and treated with either sitagliptin or placebo for 12 weeks. Plaque size and plaque composition were analysed using Oil Red O staining and immunohistochemistry. Furthermore, in vitro experiments with the modified Boyden chamber and with gelatine zymography were performed to analyse the effects of GLP-1 on isolated human monocyte migration and metalloproteinase-9 (MMP-9) release. Results Treatment of Apoe β/β mice with sitagliptin significantly reduced plaque macrophage infiltration (the aortic root and aortic arch both showing a 67% decrease; pβ<β0.05) and plaque MMP-9 levels (aortic root showing a 69% and aortic arch a 58% reduction; both pβ<β0.01) compared with controls. Moreover, sitagliptin significantly increased plaque collagen content more than twofold (aortic root showing an increase of 58% and aortic arch an increase of 73%; both pβ<β0.05) compared with controls but did not change overall lesion size (8.1βΒ±β3.5% vs 5.1βΒ±β2.5% for sitagliptin vs controls; pβ=βNS). In vitro, pretreatment of isolated human monocytes with GLP-1 significantly decreased cell migration induced by both monocyte chemotactic protein-1 and by the protein known as regulated on activation, normal T cell expressed and secreted (RANTES) in a concentration-dependent manner. Furthermore, GLP-1 significantly decreased MMP-9 release from isolated human monocyte-derived macrophages. Conclusions/interpretation Sitagliptin reduces plaque inflammation and increases plaque stability, potentially by GLP-1-mediated inhibition of chemokine-induced monocyte migration and macrophage MMP-9 release. The effects observed may provide potential mechanisms for how DPP-IV inhibitors could modulate vascular disease in high-risk patients with type 2 diabetes mellitus.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {π}
- Health & Fitness
- Social Networks
- Science
Content Management System {π}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of link.springer.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {πΈ}
We're unsure if the website is profiting.
Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.
Keywords {π}
glp, plaque, sitagliptin, article, mice, content, aortic, pubmed, google, scholar, dppiv, cas, diabetes, effects, mmp, macrophage, lesions, treatment, patients, type, migration, collagen, human, levels, root, arch, controls, size, monocyte, cell, cells, study, apoe, inhibition, fig, lesion, germany, highfat, diet, monocytes, glucose, shown, data, reduces, inhibitors, dipeptidyl, peptide, atherosclerosis, activity, glucagonlike,
Topics {βοΈ}
3Β mg h-gly-pro-p-nitroaniline dpp-iv inhibitors des-fluoro-sitagliptin cd26/dipeptidyl-peptidase iv glucose/kg body weight drugs inhibit dpp-iv reduced monocyte/macrophage infiltration dpp-iv activity measurement inhibiting dpp-iv activity western blot analysis dpp-iv inhibitors influence class-matched igg served polyvinylpyrrolidone-free polycarbonate membrane chemokine-induced monocyte migration dpp-iv enzymatic activity plaque monocyte/macrophage content glucose-dependent insulinotropic polypeptide pi3k/akt-dependent pathways dpp-iv substrates include ddp-iv inhibitor treatment random high-power fields apolipoprotein e-deficient mice dpp-iv inhibitor treatment dpp-iv-inhibitor treatment cd8alpha-negative dendritic cells p-myosin light chain human monocyte-derived macrophages primary anti-mac3 antibody goat anti-macrophage-3 antigen des-fluoro-sitagliptin dipeptidyl peptidase-iv dipeptidyl peptidase activity dipeptidyl peptidase-4 inhibitor cell type-specific marker pancreatic beta cells enhancing insulin secretion macrophages reduces atherosclerosis chemokine-induced migration dyslipidemia inhibits toll research diets d12108 plaque macrophage content dpp iv/cd26 plaque macrophage infiltration dpp-iv activity influence vascular chemokine privacy choices/manage cookies dpp-iv inhibitors dpp-iv inhibitor low collagen content monocyte-derived macrophages macrophage mmp-9 production
Questions {β}
- Geelhoed-Duijvestijn PH (2007) Incretins: a new treatment option for type 2 diabetes?
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe β/β mice
description:Inhibitors of dipeptidyl peptidase-IV (DPP-IV), such as sitagliptin, increase glucagon-like peptide-1 (GLP-1) concentrations and are current treatment options for patients with type 2 diabetes mellitus. As patients with diabetes exhibit a high risk of developing severe atherosclerosis, we investigated the effect of sitagliptin on atherogenesis in Apoe
β/β mice.
Apoe
β/β mice were fed a high-fat diet and treated with either sitagliptin or placebo for 12Β weeks. Plaque size and plaque composition were analysed using Oil Red O staining and immunohistochemistry. Furthermore, in vitro experiments with the modified Boyden chamber and with gelatine zymography were performed to analyse the effects of GLP-1 on isolated human monocyte migration and metalloproteinase-9 (MMP-9) release. Treatment of Apoe
β/β mice with sitagliptin significantly reduced plaque macrophage infiltration (the aortic root and aortic arch both showing a 67% decrease; pβ<β0.05) and plaque MMP-9 levels (aortic root showing a 69% and aortic arch a 58% reduction; both pβ<β0.01) compared with controls. Moreover, sitagliptin significantly increased plaque collagen content more than twofold (aortic root showing an increase of 58% and aortic arch an increase of 73%; both pβ<β0.05) compared with controls but did not change overall lesion size (8.1βΒ±β3.5% vs 5.1βΒ±β2.5% for sitagliptin vs controls; pβ=βNS). In vitro, pretreatment of isolated human monocytes with GLP-1 significantly decreased cell migration induced by both monocyte chemotactic protein-1 and by the protein known as regulated on activation, normal T cell expressed and secreted (RANTES) in a concentration-dependent manner. Furthermore, GLP-1 significantly decreased MMP-9 release from isolated human monocyte-derived macrophages. Sitagliptin reduces plaque inflammation and increases plaque stability, potentially by GLP-1-mediated inhibition of chemokine-induced monocyte migration and macrophage MMP-9 release. The effects observed may provide potential mechanisms for how DPP-IV inhibitors could modulate vascular disease in high-risk patients with type 2 diabetes mellitus.
datePublished:2012-05-18T00:00:00Z
dateModified:2012-05-18T00:00:00Z
pageStart:2267
pageEnd:2275
sameAs:https://doi.org/10.1007/s00125-012-2582-5
keywords:
Atherosclerosis
Glucagon-like peptide-1
Incretins
Plaque stability
Type 2 diabetes
Internal Medicine
Metabolic Diseases
Human Physiology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig5_HTML.gif
isPartOf:
name:Diabetologia
issn:
1432-0428
0012-186X
volumeNumber:55
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:F. Vittone
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:University of Ulm
address:
name:Department of Internal Medicine I β Endocrinology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:A. Liberman
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:D. Vasic
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:R. Ostertag
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:M. Esser
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:D. Walcher
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:A. Ludwig
affiliation:
name:Department of Pharmacology of the RWTH Aachen
address:
name:Department of Pharmacology of the RWTH Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:N. Marx
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M. Burgmaier
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe β/β mice
description:Inhibitors of dipeptidyl peptidase-IV (DPP-IV), such as sitagliptin, increase glucagon-like peptide-1 (GLP-1) concentrations and are current treatment options for patients with type 2 diabetes mellitus. As patients with diabetes exhibit a high risk of developing severe atherosclerosis, we investigated the effect of sitagliptin on atherogenesis in Apoe
β/β mice.
Apoe
β/β mice were fed a high-fat diet and treated with either sitagliptin or placebo for 12Β weeks. Plaque size and plaque composition were analysed using Oil Red O staining and immunohistochemistry. Furthermore, in vitro experiments with the modified Boyden chamber and with gelatine zymography were performed to analyse the effects of GLP-1 on isolated human monocyte migration and metalloproteinase-9 (MMP-9) release. Treatment of Apoe
β/β mice with sitagliptin significantly reduced plaque macrophage infiltration (the aortic root and aortic arch both showing a 67% decrease; pβ<β0.05) and plaque MMP-9 levels (aortic root showing a 69% and aortic arch a 58% reduction; both pβ<β0.01) compared with controls. Moreover, sitagliptin significantly increased plaque collagen content more than twofold (aortic root showing an increase of 58% and aortic arch an increase of 73%; both pβ<β0.05) compared with controls but did not change overall lesion size (8.1βΒ±β3.5% vs 5.1βΒ±β2.5% for sitagliptin vs controls; pβ=βNS). In vitro, pretreatment of isolated human monocytes with GLP-1 significantly decreased cell migration induced by both monocyte chemotactic protein-1 and by the protein known as regulated on activation, normal T cell expressed and secreted (RANTES) in a concentration-dependent manner. Furthermore, GLP-1 significantly decreased MMP-9 release from isolated human monocyte-derived macrophages. Sitagliptin reduces plaque inflammation and increases plaque stability, potentially by GLP-1-mediated inhibition of chemokine-induced monocyte migration and macrophage MMP-9 release. The effects observed may provide potential mechanisms for how DPP-IV inhibitors could modulate vascular disease in high-risk patients with type 2 diabetes mellitus.
datePublished:2012-05-18T00:00:00Z
dateModified:2012-05-18T00:00:00Z
pageStart:2267
pageEnd:2275
sameAs:https://doi.org/10.1007/s00125-012-2582-5
keywords:
Atherosclerosis
Glucagon-like peptide-1
Incretins
Plaque stability
Type 2 diabetes
Internal Medicine
Metabolic Diseases
Human Physiology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2582-5/MediaObjects/125_2012_2582_Fig5_HTML.gif
isPartOf:
name:Diabetologia
issn:
1432-0428
0012-186X
volumeNumber:55
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:F. Vittone
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:University of Ulm
address:
name:Department of Internal Medicine I β Endocrinology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:A. Liberman
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:D. Vasic
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:R. Ostertag
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:M. Esser
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:D. Walcher
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
type:Person
name:A. Ludwig
affiliation:
name:Department of Pharmacology of the RWTH Aachen
address:
name:Department of Pharmacology of the RWTH Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
name:N. Marx
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M. Burgmaier
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Diabetologia
issn:
1432-0428
0012-186X
volumeNumber:55
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
name:University of Ulm
address:
name:Department of Internal Medicine I β Endocrinology, University of Ulm, Ulm, Germany
type:PostalAddress
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
name:Department of Pharmacology of the RWTH Aachen
address:
name:Department of Pharmacology of the RWTH Aachen, Aachen, Germany
type:PostalAddress
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:F. Vittone
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:University of Ulm
address:
name:Department of Internal Medicine I β Endocrinology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:A. Liberman
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
name:D. Vasic
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:R. Ostertag
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:M. Esser
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
name:D. Walcher
affiliation:
name:University of Ulm
address:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
type:PostalAddress
type:Organization
name:A. Ludwig
affiliation:
name:Department of Pharmacology of the RWTH Aachen
address:
name:Department of Pharmacology of the RWTH Aachen, Aachen, Germany
type:PostalAddress
type:Organization
name:N. Marx
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
email:[email protected]
name:M. Burgmaier
affiliation:
name:University Hospital Aachen
address:
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
name:Department of Internal Medicine I β Endocrinology, University of Ulm, Ulm, Germany
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
name:Department of Internal Medicine II β Cardiology, University of Ulm, Ulm, Germany
name:Department of Pharmacology of the RWTH Aachen, Aachen, Germany
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
name:Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany
External Links {π}(155)
- How much profit is https://www.springernature.com/gp/authors making per month?
- What is the monthly revenue of https://link.springernature.com/home/?
- How much profit does https://order.springer.com/public/cart generate?
- What is the earnings of https://mc.manuscriptcentral.com/diabetologia?
- What's the monthly money flow for https://beta.springernature.com/pre-submission?journalId=125?
- How much income does https://doi.org/10.1185%2F030079906X162746 have?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17407649 earn?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20DPP-4%3A%20a%20new%20therapeutic%20approach%20for%20the%20treatment%20of%20type%202%20diabetes&journal=Curr%20Med%20Res%20Opin&doi=10.1185%2F030079906X162746&volume=23&pages=919-931&publication_year=2007&author=Pratley%2CRE&author=Salsali%2CA
- See how much https://doi.org/10.1152%2Fajpendo.00237.2004 makes per month
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15353407's revenue stream
- How much profit does http://scholar.google.com/scholar_lookup?&title=Effects%20of%20glucagon-like%20peptide-1%20on%20endothelial%20function%20in%20type%202%20diabetes%20patients%20with%20stable%20coronary%20artery%20disease&journal=Am%20J%20Physiol%20Endocrinol%20Metab&doi=10.1152%2Fajpendo.00237.2004&volume=287&pages=E1209-E1215&publication_year=2004&author=Nystrom%2CT&author=Gutniak%2CMK&author=Zhang%2CQ make?
- What is the earnings of https://doi.org/10.1016%2Fj.bbrc.2009.10.015?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19850014 generate?
- Profit of http://scholar.google.com/scholar_lookup?&title=Exendin-4%2C%20a%20GLP-1%20receptor%20agonist%2C%20directly%20induces%20adiponectin%20expression%20through%20protein%20kinase%20A%20pathway%20and%20prevents%20inflammatory%20adipokine%20expression&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2009.10.015&volume=390&pages=613-618&publication_year=2009&author=Kim%20Chung%20le%2CT&author=Hosaka%2CT&author=Yoshida%2CM
- How much does https://doi.org/10.1016%2Fj.peptides.2009.06.019 gross monthly?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19560500 make?
- http://scholar.google.com/scholar_lookup?&title=Glucagon-like%20peptide-1%20protects%20mesenteric%20endothelium%20from%20injury%20during%20inflammation&journal=Peptides&doi=10.1016%2Fj.peptides.2009.06.019&volume=30&pages=1735-1741&publication_year=2009&author=Dozier%2CKC&author=Cureton%2CEL&author=Kwan%2CRO&author=Curran%2CB&author=Sadjadi%2CJ&author=Victorino%2CGP's financial summary
- What's the financial intake of https://doi.org/10.2337%2Fdiabetes.54.1.146?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15616022?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Glucagon-like%20peptide%201%20can%20directly%20protect%20the%20heart%20against%20ischemia%2Freperfusion%20injury&journal=Diabetes&doi=10.2337%2Fdiabetes.54.1.146&volume=54&pages=146-151&publication_year=2005&author=Bose%2CAK&author=Mocanu%2CMM&author=Carr%2CRD&author=Brand%2CCL&author=Yellon%2CDM?
- What's the monthly money flow for https://doi.org/10.1016%2Fj.mce.2010.04.022?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20452396's earnings
- Find out how much http://scholar.google.com/scholar_lookup?&title=Exendin-4%20stimulates%20proliferation%20of%20human%20coronary%20artery%20endothelial%20cells%20through%20eNOS-%2C%20PKA-%20and%20PI3K%2FAkt-dependent%20pathways%20and%20requires%20GLP-1%20receptor&journal=Mol%20Cell%20Endocrinol&doi=10.1016%2Fj.mce.2010.04.022&volume=325&pages=26-35&publication_year=2010&author=Erdogdu%2CO&author=Nathanson%2CD&author=Sjoholm%2CA&author=Nystrom%2CT&author=Zhang%2CQ earns monthly
- How much does https://doi.org/10.2337%2Fdb09-1618 earn?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20368408 earning monthly?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Sitagliptin%20%28MK0431%29%20inhibition%20of%20dipeptidyl%20peptidase%20IV%20decreases%20nonobese%20diabetic%20mouse%20CD4%2B%20T%20cell%20migration%20through%20incretin-dependent%20and%20-independent%20pathways&journal=Diabetes&doi=10.2337%2Fdb09-1618&volume=59&pages=1739-1750&publication_year=2010&author=Kim%2CSJ&author=Nian%2CC&author=McIntosh%2CCH?
- Learn about the earnings of https://doi.org/10.2337%2Fdb08-1101
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19073764 rake in every month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Dipeptidyl%20peptidase%20IV%20inhibition%20with%20MK0431%20improves%20islet%20graft%20survival%20in%20diabetic%20NOD%20mice%20partially%20via%20T%20cell%20modulation&journal=Diabetes&doi=10.2337%2Fdb08-1101&volume=58&pages=641-651&publication_year=2009&author=Kim%2CSJ&author=Nian%2CC&author=Doudet%2CDJ&author=McIntosh%2CCH generate?
- Monthly income for https://doi.org/10.1161%2FCIRCULATIONAHA.111.041418
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22007077
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Long-term%20dipeptidyl-peptidase%204%20inhibition%20reduces%20atherosclerosis%20and%20inflammation%20via%20effects%20on%20monocyte%20recruitment%20and%20chemotaxis&journal=Circulation&doi=10.1161%2FCIRCULATIONAHA.111.041418&volume=124&pages=2338-2349&publication_year=2011&author=Shah%2CZ&author=Kampfrath%2CT&author=Deiuliis%2CJA
- Get to know what's the income of https://doi.org/10.1016%2Fj.vph.2011.05.001
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21664294?
- How much money does http://scholar.google.com/scholar_lookup?&title=Cardiovascular%20effects%20of%20DPP-4%20inhibition%3A%20beyond%20GLP-1&journal=Vascul%20Pharmacol&doi=10.1016%2Fj.vph.2011.05.001&volume=55&pages=10-16&publication_year=2011&author=Fadini%2CGP&author=Avogaro%2CA make?
- What's the revenue for https://doi.org/10.1111%2Fj.1742-1241.2006.01246.x?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17156104 income
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20tolerability%20of%20the%20dipeptidyl%20peptidase-4%20inhibitor%20sitagliptin%20as%20monotherapy%20over%2012%C2%A0weeks%20in%20patients%20with%20type%202%20diabetes&journal=Int%20J%20Clin%20Pract&doi=10.1111%2Fj.1742-1241.2006.01246.x&volume=61&pages=171-180&publication_year=2007&author=Scott%2CR&author=Wu%2CM&author=Sanchez%2CM&author=Stein%2CP
- What's the income of https://doi.org/10.1177%2F0091270008316885?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18353996?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Effect%20of%20sitagliptin%2C%20a%20dipeptidyl%20peptidase-4%20inhibitor%2C%20on%20blood%20pressure%20in%20nondiabetic%20patients%20with%20mild%20to%20moderate%20hypertension&journal=J%20Clin%20Pharmacol&doi=10.1177%2F0091270008316885&volume=48&pages=592-598&publication_year=2008&author=Mistry%2CGC&author=Maes%2CAL&author=Lasseter%2CKC
- Profit of https://doi.org/10.1016%2Fj.jacc.2011.07.053
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22240132?
- http://scholar.google.com/scholar_lookup?&title=A%20dipeptidyl%20peptidase-4%20inhibitor%2C%20des-fluoro-sitagliptin%2C%20improves%20endothelial%20function%20and%20reduces%20atherosclerotic%20lesion%20formation%20in%20apolipoprotein%20E-deficient%20mice&journal=J%20Am%20Coll%20Cardiol&doi=10.1016%2Fj.jacc.2011.07.053&volume=59&pages=265-276&publication_year=2012&author=Matsubara%2CJ&author=Sugiyama%2CS&author=Sugamura%2CK income
- Get to know what's the income of https://doi.org/10.1084%2Fjem.20061737
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17296788's earnings
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Dyslipidemia%20inhibits%20Toll-like%20receptor-induced%20activation%20of%20CD8alpha-negative%20dendritic%20cells%20and%20protective%20Th1%20type%20immunity&journal=J%20Exp%20Med&doi=10.1084%2Fjem.20061737&volume=204&pages=441-452&publication_year=2007&author=Shamshiev%2CAT&author=Ampenberger%2CF&author=Ernst%2CB&author=Rohrer%2CL&author=Marsland%2CBJ&author=Kopf%2CM
- Revenue of https://doi.org/10.5551%2Fjat.13.308
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17192695 have?
- http://scholar.google.com/scholar_lookup?&title=A%20selective%20NFkappaB%20inhibitor%2C%20DHMEQ%2C%20reduced%20atherosclerosis%20in%20ApoE-deficient%20mice&journal=J%20Atheroscler%20Thromb&doi=10.5551%2Fjat.13.308&volume=13&pages=308-313&publication_year=2006&author=Chiba%2CT&author=Kondo%2CY&author=Shinozaki%2CS's total income per month
- How much revenue does https://doi.org/10.2337%2Fdb05-1602 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16731832 pull in?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Chronic%20inhibition%20of%20dipeptidyl%20peptidase-4%20with%20a%20sitagliptin%20analog%20preserves%20pancreatic%20beta-cell%20mass%20and%20function%20in%20a%20rodent%20model%20of%20type%202%20diabetes&journal=Diabetes&doi=10.2337%2Fdb05-1602&volume=55&pages=1695-1704&publication_year=2006&author=Mu%2CJ&author=Woods%2CJ&author=Zhou%2CYP generate?
- Learn how profitable https://doi.org/10.1074%2Fjbc.274.48.34053 is on a monthly basis
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10567372?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Sequence%2C%20purification%2C%20and%20cloning%20of%20an%20intracellular%20serine%20protease%2C%20quiescent%20cell%20proline%20dipeptidase&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.274.48.34053&volume=274&pages=34053-34058&publication_year=1999&author=Underwood%2CR&author=Chiravuri%2CM&author=Lee%2CH have monthly?
- See how much https://doi.org/10.1046%2Fj.1432-1327.2000.01634.x makes per month
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10951221?
- How much does http://scholar.google.com/scholar_lookup?&title=Molecular%20characterization%20of%20dipeptidyl%20peptidase%20activity%20in%20serum%3A%20soluble%20CD26%2Fdipeptidyl%20peptidase%20IV%20is%20responsible%20for%20the%20release%20of%20X-Pro%20dipeptides&journal=Eur%20J%20Biochem&doi=10.1046%2Fj.1432-1327.2000.01634.x&volume=267&pages=5608-5613&publication_year=2000&author=Durinx%2CC&author=Lambeir%2CAM&author=Bosmans%2CE bring in each month?
- How much does https://doi.org/10.1053%2Fmeta.2003.50014 pull in?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12524666 generate monthly?
- See how much http://scholar.google.com/scholar_lookup?&title=Enteroinsular%20axis%20of%20db%2Fdb%20mice%20and%20efficacy%20of%20dipeptidyl%20peptidase%20IV%20inhibition&journal=Metabolism&doi=10.1053%2Fmeta.2003.50014&volume=52&pages=81-86&publication_year=2003&author=Nagakura%2CT&author=Yasuda%2CN&author=Yamazaki%2CK&author=Ikuta%2CH&author=Tanaka%2CI makes per month
- What are the total earnings of https://doi.org/10.1161%2F01.ATV.0000116027.81513.68?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14707040?
- Get to know http://scholar.google.com/scholar_lookup?&title=C-peptide%20colocalizes%20with%20macrophages%20in%20early%20arteriosclerotic%20lesions%20of%20diabetic%20subjects%20and%20induces%20monocyte%20chemotaxis%20in%20vitro&journal=Arterioscler%20Thromb%20Vasc%20Biol&doi=10.1161%2F01.ATV.0000116027.81513.68&volume=24&pages=540-545&publication_year=2004&author=Marx%2CN&author=Walcher%2CD&author=Raichle%2CC's earnings
- Find out how much https://doi.org/10.1016%2FS0002-9440%2810%2965540-X earns monthly
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9665460 is on a monthly basis
- How much does http://scholar.google.com/scholar_lookup?&title=Macrophages%20in%20human%20atheroma%20contain%20PPARgamma%3A%20differentiation-dependent%20peroxisomal%20proliferator-activated%20receptor%20gamma%28PPARgamma%29%20expression%20and%20reduction%20of%20MMP-9%20activity%20through%20PPARgamma%20activation%20in%20mononuclear%20phagocytes%20in%20vitro&journal=Am%20J%20Pathol&doi=10.1016%2FS0002-9440%2810%2965540-X&volume=153&pages=17-23&publication_year=1998&author=Marx%2CN&author=Sukhova%2CG&author=Murphy%2CC&author=Libby%2CP&author=Plutzky%2CJ make?
- Income figures for https://doi.org/10.1152%2Fphysrev.00034.2006
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17928588's total income per month
- http://scholar.google.com/scholar_lookup?&title=The%20physiology%20of%20glucagon-like%20peptide%201&journal=Physiol%20Rev&doi=10.1152%2Fphysrev.00034.2006&volume=87&pages=1409-1439&publication_year=2007&author=Holst%2CJJ's revenue stream
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17379930 earns monthly
- What's http://scholar.google.com/scholar_lookup?&title=Incretins%3A%20a%20new%20treatment%20option%20for%20type%202%20diabetes%3F&journal=Neth%20J%20Med&volume=65&pages=60-64&publication_year=2007&author=Geelhoed-Duijvestijn%2CPH's gross income?
- Revenue of https://doi.org/10.1517%2F14728220903241633
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19758106?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Glucose%20lowering%20and%20anti-atherogenic%20effects%20of%20incretin-based%20therapies%3A%20GLP-1%20analogues%20and%20DPP-4-inhibitors&journal=Expert%20Opin%20Investig%20Drugs&doi=10.1517%2F14728220903241633&volume=18&pages=1495-1503&publication_year=2009&author=Rizzo%2CM&author=Rizvi%2CAA&author=Spinas%2CGA&author=Rini%2CGB&author=Berneis%2CK is on a monthly basis
- How much does https://doi.org/10.1016%2Fj.neures.2006.04.008 net monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16720054 make?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Glucagon-like%20peptide-1%20inhibits%20LPS-induced%20IL-1beta%20production%20in%20cultured%20rat%20astrocytes&journal=Neurosci%20Res&doi=10.1016%2Fj.neures.2006.04.008&volume=55&pages=352-360&publication_year=2006&author=Iwai%2CT&author=Ito%2CS&author=Tanimitsu%2CK&author=Udagawa%2CS&author=Oka%2CJ?
- How much cash flow does https://doi.org/10.1111%2Fj.1365-2133.2008.08515.x have monthly?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18384439 have monthly?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=CD26%2Fdipeptidyl-peptidase%20IV%20in%20psoriatic%20skin%3A%20upregulation%20and%20topographical%20changes&journal=Br%20J%20Dermatol&doi=10.1111%2Fj.1365-2133.2008.08515.x&volume=158&pages=1264-1272&publication_year=2008&author=Lingen%2CRG&author=Kerkhof%2CPC&author=Seyger%2CMM?
- https://doi.org/10.1161%2FATVBAHA.108.170548's revenue stream
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18566294?
- How much does http://scholar.google.com/scholar_lookup?&title=Low%20tissue%20inhibitor%20of%20metalloproteinases%203%20and%20high%20matrix%20metalloproteinase%2014%20levels%20defines%20a%20subpopulation%20of%20highly%20invasive%20foam-cell%20macrophages&journal=Arterioscler%20Thromb%20Vasc%20Biol&doi=10.1161%2FATVBAHA.108.170548&volume=28&pages=1647-1653&publication_year=2008&author=Johnson%2CJL&author=Sala-Newby%2CGB&author=Ismail%2CY&author=Aguilera%2CCM&author=Newby%2CAC pull in?
- What is the earnings of https://doi.org/10.1161%2FATVBAHA.111.238402?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22015660 income
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20tissue%20inhibitor%20of%20metalloproteinase%203%20in%20macrophages%20reduces%20atherosclerosis%20in%20low-density%20lipoprotein%20receptor%20knockout%20mice&journal=Arterioscler%20Thromb%20Vasc%20Biol&doi=10.1161%2FATVBAHA.111.238402&volume=32&pages=74-81&publication_year=2012&author=Casagrande%2CV&author=Menghini%2CR&author=Menini%2CS each month?
- What's the profit of https://doi.org/10.1016%2Fj.vph.2011.03.001?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21397040 produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Acute%20DPP-4%20inhibition%20modulates%20vascular%20tone%20through%20GLP-1%20independent%20pathways&journal=Vascul%20Pharmacol&doi=10.1016%2Fj.vph.2011.03.001&volume=55&pages=2-9&publication_year=2011&author=Shah%2CZ&author=Pineda%2CC&author=Kampfrath%2CT pull in monthly?
- How much profit does https://doi.org/10.1093%2Feurheartj%2Fehq519 make?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21292680 making per month?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Fibroblast%20activation%20protein%20is%20induced%20by%20inflammation%20and%20degrades%20type%20I%20collagen%20in%20thin-cap%20fibroatheromata&journal=Eur%20Heart%20J&doi=10.1093%2Feurheartj%2Fehq519&volume=32&pages=2713-2722&publication_year=2011&author=Brokopp%2CCE&author=Schoenauer%2CR&author=Richards%2CP
- https://doi.org/10.2174%2F156802611795860933's financial summary
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21510839?
- Profit of http://scholar.google.com/scholar_lookup?&title=Current%20advances%20and%20therapeutic%20potential%20of%20agents%20targeting%20dipeptidyl%20peptidases-IV%2C%20-II%2C%208%2F9%20and%20fibroblast%20activation%20protein&journal=Curr%20Top%20Med%20Chem&doi=10.2174%2F156802611795860933&volume=11&pages=1447-1463&publication_year=2011&author=Chen%2CSJ&author=Jiaang%2CWT
- Explore the financials of https://doi.org/10.2337%2Fdb09-1694
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20068138 bring in?
- http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20monocyte%20adhesion%20to%20endothelial%20cells%20and%20attenuation%20of%20atherosclerotic%20lesion%20by%20a%20glucagon-like%20peptide-1%20receptor%20agonist%2C%20exendin-4&journal=Diabetes&doi=10.2337%2Fdb09-1694&volume=59&pages=1030-1070&publication_year=2010&author=Arakawa%2CM&author=Mita%2CT&author=Azuma%2CK's total income per month
- What's the financial intake of https://doi.org/10.2741%2F2798?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17981666 have monthly?
- Profit of http://scholar.google.com/scholar_lookup?&title=SDF-1%20%28CXCL12%29%20in%20haematopoiesis%20and%20leukaemia%3A%20impact%20of%20DPP%20IV%2FCD26&journal=Front%20Biosci&doi=10.2741%2F2798&volume=13&pages=1774-1779&publication_year=2008&author=Hildebrandt%2CM&author=Schabath%2CR
- How much money does https://doi.org/10.1161%2FCIRCULATIONAHA.107.739938 make?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18427132
- How profitable is http://scholar.google.com/scholar_lookup?&title=Cardioprotective%20and%20vasodilatory%20actions%20of%20glucagon-like%20peptide%201%20receptor%20are%20mediated%20through%20both%20glucagon-like%20peptide%201%20receptor-dependent%20and%20-independent%20pathways&journal=Circulation&doi=10.1161%2FCIRCULATIONAHA.107.739938&volume=117&pages=2340-2350&publication_year=2008&author=Ban%2CK&author=Noyan-Ashraf%2CMH&author=Hoefer%2CJ&author=Bolz%2CSS&author=Drucker%2CDJ&author=Husain%2CM?
- How much does https://doi.org/10.1001%2Fjama.287.19.2570 make?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12020339 have?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Diabetes%20and%20atherosclerosis%3A%20epidemiology%2C%20pathophysiology%2C%20and%20management&journal=JAMA&doi=10.1001%2Fjama.287.19.2570&volume=287&pages=2570-2581&publication_year=2002&author=Beckman%2CJA&author=Creager%2CMA&author=Libby%2CP generate?
- How much profit does https://doi.org/10.1161%2F01.RES.0000014225.20727.8F make?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11934839?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=PPAR%20activators%20as%20antiinflammatory%20mediators%20in%20human%20T%20lymphocytes%3A%20implications%20for%20atherosclerosis%20and%20transplantation-associated%20arteriosclerosis&journal=Circ%20Res&doi=10.1161%2F01.RES.0000014225.20727.8F&volume=90&pages=703-710&publication_year=2002&author=Marx%2CN&author=Kehrle%2CB&author=Kohlhammer%2CK?
- How much profit is https://doi.org/10.1056%2FNEJM199901143400207 making per month?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9887164's gross income?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Atherosclerosis%20%E2%80%93%20an%20inflammatory%20disease&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM199901143400207&volume=340&pages=115-126&publication_year=1999&author=Ross%2CR is on a monthly basis
- Learn about the earnings of https://doi.org/10.3810%2Fpgm.2010.05.2138
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20463410 earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=A%20systematic%20assessment%20of%20cardiovascular%20outcomes%20in%20the%20saxagliptin%20drug%20development%20program%20for%20type%202%20diabetes&journal=Postgrad%20Med&doi=10.3810%2Fpgm.2010.05.2138&volume=122&pages=16-27&publication_year=2010&author=Frederich%2CR&author=Alexander%2CJH&author=Fiedorek%2CFT make?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s00125-012-2582-5?format=refman&flavour=references bring in each month?
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=F.%20Vittone making per month?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22F.%20Vittone%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A.%20Liberman income
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A.%20Liberman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D.%20Vasic's earnings
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D.%20Vasic%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R.%20Ostertag
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R.%20Ostertag%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Esser?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Esser%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D.%20Walcher pull in?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D.%20Walcher%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A.%20Ludwig gross monthly?
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A.%20Ludwig%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N.%20Marx earn?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N.%20Marx%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Burgmaier produce monthly?
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Burgmaier%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the profit of https://s100.copyright.com/AppDispatchServlet?title=Sitagliptin%20reduces%20plaque%20macrophage%20content%20and%20stabilises%20arteriosclerotic%20lesions%20in%20Apoe%20%E2%88%92%2F%E2%88%92%20mice&author=F.%20Vittone%20et%20al&contentID=10.1007%2Fs00125-012-2582-5©right=Springer-Verlag&publication=0012-186X&publicationDate=2012-05-18&publisherName=SpringerNature&orderBeanReset=true?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1007/s00125-012-2582-5?format=refman&flavour=citation generate?
- Income figures for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- What's https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's gross income?
- Get to know what's the income of https://www.springernature.com/gp/products
- How much profit does https://www.springernature.com/gp/librarians make?
- What is the monthly revenue of https://www.springernature.com/gp/societies?
- What's the income of https://www.springernature.com/gp/partners?
- What's the financial intake of https://www.springer.com/?
- How profitable is https://www.nature.com/?
- What's the monthly income of https://www.biomedcentral.com/?
- Check the income stats for https://www.palgrave.com/
- How much revenue does https://www.apress.com/ produce monthly?
- Get to know https://www.springernature.com/gp/legal/ccpa's earnings
- How much profit does https://www.springernature.com/gp/info/accessibility make?
- How much does https://support.springernature.com/en/support/home bring in each month?
- How much money does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations make?
- Revenue of https://www.springernature.com/
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Clipboard.js
- Prism.js